BP p.l.c. (BPAQF)
OTC: BPAQF
· Real-Time Price · USD
5.66
-0.05 (-0.88%)
At close: Aug 14, 2025, 3:49 PM
BP p.l.c. Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 46.91B | 45.75B | 47.25B | 47.4B | 48.66B | 53.5B | 53.27B | 48.54B | 56.18B | 69.26B | 55.01B | 67.87B | 49.26B | 50.55B | 36.17B | 36.47B | 34.54B |
Cost of Revenue | 38.46B | 39.96B | 39.73B | 40.43B | 39.16B | 42.91B | 40.63B | 39.73B | 40.38B | 45.21B | 51.29B | 50.88B | 38.91B | 42.76B | 34.26B | 31.73B | 26.13B |
Gross Profit | 8.44B | 5.79B | 7.53B | 6.97B | 9.5B | 10.59B | 12.64B | 8.81B | 15.8B | 24.04B | 3.72B | 16.99B | 10.35B | 7.8B | 1.91B | 4.74B | 8.41B |
Operating Income | 3.93B | 1.51B | 3.22B | 3.81B | 5.51B | 5.73B | 8.63B | 5.71B | 12.63B | 21.19B | 1.18B | 13.76B | 8.64B | 5.74B | 183M | 2.63B | 6.53B |
Interest Income | 394.84M | 1.5B | 450.53M | 414.84M | 379.3M | 614.64M | 395.17M | 383.27M | 251.73M | 626.9M | 150.94M | 137.78M | 189.99M | 259.78M | 158M | 82M | 82M |
Pretax Income | 2.62B | -503M | 1.4B | 739.5M | 4.14B | 1.27B | 7.31B | 3.49B | 11.85B | 16.9B | 1.98B | 14.06B | -17.54B | 4.04B | -495M | 5.14B | 6.54B |
Net Income | 704.56M | -1.96B | 206M | -129.26M | 2.26B | 371M | 4.86B | 1.79B | 8.22B | 10.8B | -2.16B | 9.26B | -20.38B | 2.33B | -2.54B | 3.12B | 4.67B |
Selling & General & Admin | 4.41B | 4.1B | 3.93B | 3.16B | 3.99B | 4.86B | 4.46B | 3.83B | 3.75B | 3.65B | 3.26B | 3.45B | 3.08B | 3.37B | 3.08B | 2.87B | 2.62B |
Research & Development | n/a | n/a | n/a | n/a | n/a | 298M | n/a | n/a | n/a | 274M | n/a | n/a | n/a | 266M | n/a | n/a | n/a |
Other Expenses | n/a | 176M | 372M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.51B | 4.27B | 4.3B | 3.16B | 3.99B | 4.86B | 4.55B | 4.13B | 3.85B | 3.79B | 3.49B | 3.58B | 3.17B | 3.47B | 3.19B | 2.98B | 2.71B |
Interest Expense | 1.35B | 1.26B | 1.13B | 1.22B | 1.07B | 1.07B | 1B | 932.82M | 855.66M | 859.93M | 616.09M | 539.5M | 650.27M | 761.28M | 693M | 682M | 723M |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.01B | -229.85M | 123.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 42.98B | 44.24B | 44.03B | 43.59B | 43.15B | 47.77B | 45.19B | 43.86B | 44.23B | 49.01B | 54.78B | 54.46B | 42.09B | 46.22B | 37.45B | 34.71B | 28.85B |
Income Tax Expense | 2.2B | 1.12B | 1.03B | 1.19B | 2.21B | 680.31M | 2.24B | 1.54B | 3.42B | 5.74B | 3.96B | 4.53B | 2.53B | 1.46B | 1.85B | 1.78B | 1.64B |
Shares Outstanding (Basic) | 15.78B | 15.89B | 16.32B | 16.59B | 16.75B | 16.83B | 17.2B | 17.52B | 17.89B | 18.18B | 18.89B | 19.39B | 19.51B | 19.8B | 20.15B | 20.27B | 20.3B |
Shares Outstanding (Diluted) | 16.1B | 15.89B | 16.71B | 16.59B | 17.15B | 17.27B | 17.61B | 17.9B | 18.24B | 18.51B | 18.89B | 19.62B | 19.51B | 19.95B | 20.15B | 20.37B | 20.39B |
EPS (Basic) | 0.04 | -0.12 | 0.01 | -0.01 | 0.13 | 0.02 | 0.27 | 0.10 | 0.47 | 0.61 | -0.11 | 0.46 | -1.02 | 0.12 | -0.12 | 0.15 | 0.23 |
EPS (Diluted) | 0.04 | -0.12 | 0.01 | -0.01 | 0.13 | 0.02 | 0.27 | 0.10 | 0.46 | 0.60 | -0.11 | 0.46 | -1.02 | 0.12 | -0.12 | 0.15 | 0.23 |
EBITDA | 8.26B | 5.17B | 6.62B | 6.06B | 9.34B | 6.5B | 11.97B | 8.34B | 16.36B | 21.79B | 3.9B | 17.02B | -14.2B | 7.55B | 2.78B | 5.41B | 9.12B |
EBIT | 3.97B | 788M | 2.5B | 2.47B | 5.21B | 2.12B | 8.35B | 4.41B | 12.51B | 17.96B | 2.63B | 14.62B | -16.88B | 3.67B | 198M | 5.82B | 7.26B |
Depreciation & Amortization | 4.29B | 4.38B | 4.12B | 4.11B | 4.13B | 4.17B | 4B | 3.98B | 3.86B | 3.83B | 3.29B | 3.41B | 3.55B | 3.87B | 3.86B | 3.59B | 3.37B |